Dr. Antonio Strafella at Toronto Western Hospital is using advanced PET imaging to explore the possibility that Parkinson’s disease may actually represent multiple, distinct neurological conditions. By injecting a tracer into the bloodstream, he can measure the density of synapses in the brain, which decline as dopamine-producing cells are lost. This breakthrough allows researchers to observe disease progression in living patients, rather than at autopsy.
Blog & News
Empower the Parkinson’s community in British Columbia by providing resources and services to enable self-management, self-reliance, and self-advocacy.

Filter posts: News | Annual Reports | Contributor’s Corner | Inspirational Stories | Media & Press | Research
“When Life Gives You Parkinson’s” podcast launches September 12
Sep 10, 2018 | News
What happens When Life Gives You Parkinson's? That's the question that Larry Gifford is working to answer in a new podcast venture. Launching Wednesday, September 12, this series shares Gifford's journey as he comes to terms with the disease that affects over...
Registration for the 5th World Parkinson Congress opens today!
Aug 31, 2018 | News
The triennial World Parkinson Congresses provide an international forum for dialogue on the latest scientific discoveries, medical practices, and caregiver initiatives related to Parkinson’s disease. The 5th World Parkinson Congress will be held in Kyoto, Japan...
SINEMET® (levodopa and carbidopa) shortage in Canada
Aug 30, 2018 | News
Merck Canada Inc., distributor of SINEMET® (levodopa and carbidopa) in Canada, has released a statement noting that there are global manufacturing delays in the production and resupply of these products. The limiACted supply, which may result in back orders, is...
PSBC Welcomes Amy Ma, Education & Support Services Coordinator
Aug 24, 2018 | News
We are pleased to announce that Amy Ma has joined Parkinson Society British Columbia (PSBC) as Education & Support Services Coordinator. Amy completed her Bachelor of Arts in Psychology at the University of British Columbia in 2017. She has since worked...
Development of a Method to Determine the Relationship between Parkinson’s Disease and the GCase Enzyme
Aug 1, 2018 | Research
Dr. Christina Gros has developed a chemical probe to measure glucocerebrosidase (GCase) activity, an enzyme linked to Parkinson’s disease. Mutations in the GCase gene are a major genetic risk factor for PD, and its activity decreases in patients. Gros’s method, using a simple blood sample, could enable earlier detection of PD before symptoms appear and help track disease progression and treatment responses.
Parkinson’s Art Exhibit: Opening August 1!
Jul 25, 2018 | News
Parkinson Society British Columbia (PSBC) is hosting an art exhibit throughout August at “the Moat” gallery space at the Library Square Conference Centre. This show celebrates the strength and creativity of people with Parkinson’s and their carepartners and...
Viewpoints: Summer 2018
Jul 1, 2018 | Viewpoints
The Summer 2018 issue of Viewpoints highlights research on early Parkinson’s detection by measuring GCase enzyme activity, co-funding projects on live cell imaging and neuronal patterns. Dr. Daryl Wile addresses pain management in Parkinson’s, emphasizing a...
Share your Parkinson’s journey with Global BC!
Jun 20, 2018 | News
On April 11, in recognition of World Parkinson’s Day, CKNW and Global BC ran awareness pieces featuring Larry Gifford, who is newly diagnosed with young onset Parkinson’s disease (YOPD), and an active member of the Parkinson Society BC community....